Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorapaxar in the Human Endotoxemia Model
NCT02875028Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jun 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vorapaxar in Systemic Inflammatory Response Syndrome (SIRS), sepsis, sponsored by Medical University of Vienna. Started Jun 2016; status: completed.
02
Drugs
vorapaxar
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)sepsis
Beyond the preview
Go deeper on NCT02875028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02875028.